Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (31-40 of 536) with videos related to

Pageof 54
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|September 5, 2012
Determination of cellular uptake and intracellular levels of Cenersen (Aezea(®), EL625), a p53 antisense oligonucleotide in acute myeloid leukemia cellsHouda Alachkar, Zhiliang Xie, Guido Marcucci, et al.
Current Opinion in Hematology|May 27, 2009
Molecular signatures in acute myeloid leukemiaKrzysztof Mrózek, Michael D Radmacher, Clara D Bloomfield, et al.
Annals of Hematology|May 24, 2024
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)Adam Braun, Salman Otoukesh, Jose Tinajero, et al.
British Journal of Haematology|May 10, 2007
Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewClaudia D Baldus, Krzysztof Mrózek, Guido Marcucci, et al.
Current Hematologic Malignancy Reports|April 29, 2010
MicroRNA expression in acute myeloid leukemiaGuido Marcucci, Michael D Radmacher, Krzysztof Mrózek, et al.
Journal of Clinical Pharmacology|April 16, 2005
Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromesGuido Marcucci, Lewis Silverman, Mark Eller, et al.
Blood|November 4, 2010
The prognostic and functional role of microRNAs in acute myeloid leukemiaGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.
Leukemia & Lymphoma|February 28, 2023
Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclaxAhmed Aribi, Amandeep Salhotra, Brian Ball, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 28, 2006
Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomesShih-Jiuan Chiu, Shujun Liu, Danilo Perrotti, et al.
Blood Reviews|August 22, 2018
The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implicationsElisa Quiroz, Ibrahim Aldoss, Vinod Pullarkat, et al.
Pageof 54

Showing results (31-40 of 536) with videos related to

Sort By:
Pageof 54
Journal of Pharmaceutical and Biomedical Analysis|September 5, 2012
Determination of cellular uptake and intracellular levels of Cenersen (Aezea(®), EL625), a p53 antisense oligonucleotide in acute myeloid leukemia cellsHouda Alachkar, Zhiliang Xie, Guido Marcucci, et al.
Current Opinion in Hematology|May 27, 2009
Molecular signatures in acute myeloid leukemiaKrzysztof Mrózek, Michael D Radmacher, Clara D Bloomfield, et al.
Annals of Hematology|May 24, 2024
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)Adam Braun, Salman Otoukesh, Jose Tinajero, et al.
British Journal of Haematology|May 10, 2007
Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewClaudia D Baldus, Krzysztof Mrózek, Guido Marcucci, et al.
Current Hematologic Malignancy Reports|April 29, 2010
MicroRNA expression in acute myeloid leukemiaGuido Marcucci, Michael D Radmacher, Krzysztof Mrózek, et al.
Journal of Clinical Pharmacology|April 16, 2005
Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromesGuido Marcucci, Lewis Silverman, Mark Eller, et al.
Blood|November 4, 2010
The prognostic and functional role of microRNAs in acute myeloid leukemiaGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.
Leukemia & Lymphoma|February 28, 2023
Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclaxAhmed Aribi, Amandeep Salhotra, Brian Ball, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 28, 2006
Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomesShih-Jiuan Chiu, Shujun Liu, Danilo Perrotti, et al.
Blood Reviews|August 22, 2018
The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implicationsElisa Quiroz, Ibrahim Aldoss, Vinod Pullarkat, et al.
Pageof 54